Creative Planning Thermo Fisher Scientific Inc. Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Creative Planning holds 101,174 shares of TMO stock, worth $51.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

101,174

Previous 98,102 3.13%

Holding current value

$51.9 Million

Previous $54.3 Million 15.35%

% of portfolio

0.06%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$531.86 - $624.21 $1.63 Million - $1.92 Million	3,072 Added 3.13%	101,174 $62.6 Million
Q2 2024 Aug 15, 2024	BUY	$541.52 - $599.02 $1.44 Million - $1.6 Million	2,668 Added 2.8%	98,102 $54.3 Million
Q1 2024 May 10, 2024	BUY	$528.82 - $599.43 $3.4 Million - $3.85 Million	6,428 Added 7.22%	95,434 $55.5 Million
Q4 2023 Feb 14, 2024	SELL	$431.41 - $532.94 $12.1 Million - $14.9 Million	-27,935 Reduced 23.89%	89,006 $47.2 Million
Q3 2023 Nov 16, 2023	BUY	$498.29 - $574.41 $18.2 Million - $21 Million	36,587 Added 45.53%	116,941 $59.2 Million
Q2 2023 Jul 21, 2023	SELL	$508.46 - $591.13 $975,226 - $1.13 Million	-1,918 Reduced 2.33%	80,354 $41.9 Million
Q1 2023 May 15, 2023	BUY	$535.0 - $604.82 $877,935 - $992,509	1,641 Added 2.04%	82,272 $47.4 Million
Q4 2022 Feb 10, 2023	BUY	$484.71 - $571.37 $3.14 Million - $3.7 Million	6,469 Added 8.72%	80,631 $44.4 Million
Q3 2022 Nov 03, 2022	SELL	$507.19 - $604.49 $2.42 Million - $2.89 Million	-4,773 Reduced 6.05%	74,162 $37.6 Million
Q2 2022 Aug 15, 2022	BUY	$500.9 - $612.21 $3.14 Million - $3.84 Million	6,275 Added 8.64%	78,935 $42.9 Million
Q1 2022 May 16, 2022	BUY	$524.0 - $644.92 $20.9 Million - $25.8 Million	39,944 Added 122.09%	72,660 $42.9 Million
Q4 2021 Feb 11, 2022	BUY	$569.0 - $667.24 $386,920 - $453,723	680 Added 2.12%	32,716 $21.8 Million
Q3 2021 Nov 10, 2021	BUY	$509.53 - $609.78 $139,101 - $166,469	273 Added 0.86%	32,036 $18.3 Million
Q2 2021 Aug 04, 2021	SELL	$441.0 - $508.24 $2.46 Million - $2.83 Million	-5,567 Reduced 14.91%	31,763 $16 Million
Q1 2021 Apr 30, 2021	BUY	$439.85 - $518.83 $690,564 - $814,563	1,570 Added 4.39%	37,330 $17 Million
Q4 2020 Jan 29, 2021	BUY	$435.06 - $527.66 $531,208 - $644,272	1,221 Added 3.54%	35,760 $16.7 Million
Q3 2020 Nov 05, 2020	BUY	$359.77 - $441.52 $1.8 Million - $2.21 Million	5,011 Added 16.97%	34,539 $15.3 Million
Q2 2020 Jul 23, 2020	SELL	$275.2 - $362.34 $1,376 - $1,811	-5 Reduced 0.02%	29,528 $10.7 Million
Q1 2020 May 05, 2020	SELL	$255.3 - $340.05 $86,802 - $115,617	-340 Reduced 1.14%	29,533 $8.38 Million
Q4 2019 Jan 30, 2020	BUY	$271.93 - $328.04 $156,359 - $188,623	575 Added 1.96%	29,873 $9.71 Million
Q3 2019 Nov 01, 2019	SELL	$268.46 - $305.43 $319,735 - $363,767	-1,191 Reduced 3.91%	29,298 $8.53 Million
Q2 2019 Jul 26, 2019	BUY	$257.51 - $295.55 $352,531 - $404,607	1,369 Added 4.7%	30,489 $8.95 Million
Q1 2019 Apr 24, 2019	BUY	$212.17 - $273.72 $143,002 - $184,487	674 Added 2.37%	29,120 $7.97 Million
Q4 2018 Feb 01, 2019	BUY	$208.47 - $251.98 $381,708 - $461,375	1,831 Added 6.88%	28,446 $6.37 Million
Q3 2018 Oct 25, 2018	BUY	$205.57 - $244.32 $284,714 - $338,383	1,385 Added 5.49%	26,615 $6.5 Million
Q2 2018 Jul 20, 2018	BUY	$203.14 - $219.53 $401,607 - $434,010	1,977 Added 8.5%	25,230 $5.23 Million
Q1 2018 Apr 18, 2018	BUY	$192.98 - $224.11 $44,964 - $52,217	233 Added 1.01%	23,253 $4.8 Million
Q4 2017 Jan 17, 2018	BUY	$182.03 - $200.37 $471,821 - $519,359	2,592 Added 12.69%	23,020 $4.37 Million
Q3 2017 Oct 17, 2017	BUY	$171.74 - $194.04 $3.51 Million - $3.96 Million	20,428	20,428 $3.87 Million

Others Institutions Holding TMO

# of Institutions

2,829

Shares Held

334M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $201B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Thermo Fisher Scientific Inc. Transaction History